A
Again
Helping companies go carbon neutral by transforming their CO2 emission into valuable products
About Again
Again.Bio is a pioneering startup that has developed an innovative solution to address the global carbon dioxide (CO2) emissions problem. The company operates in the environmental technology market, specifically focusing on carbon capture and conversion. Their unique approach involves the use of ancient bacteria and modern technology to convert CO2 into carbon-negative chemicals.
The company's business model is centered around their proprietary bioreactor, which captures CO2 emissions at the source and ferments them into useful chemicals. This process not only reduces the amount of CO2 in the atmosphere but also creates a valuable product that can be sold, providing a dual revenue stream.
Again.Bio serves a wide range of clients, from industries with high CO2 emissions looking to reduce their carbon footprint, to businesses interested in purchasing the carbon-negative chemicals produced. The company's solution is particularly appealing as it offers a practical and immediate way to achieve carbon neutrality, a goal that many businesses and governments are striving for.
The company's team, led by co-founders Dr. Torbjørn Jensen and Prof. Alex Nielsen, is currently expanding, indicating potential for growth and further development of their technology.
In summary, Again.Bio is a promising startup with a unique, practical solution to a pressing global issue. They have the potential to disrupt the environmental technology market and contribute significantly to global efforts to combat climate change.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- Søborg, Denmark
- Employees
- 76
- Open positions
- 10
- Dealroom signal
- 87.0/100
- Sector
- Chemicals, Biotechnology, Chemical, Synthetic Biology, Spinout, Sustainable Development Goals, Carbon Capture and Storage, Advanced Materials, Fermentation, Climate Tech, Circular Economy
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Jul 2024 | $43M | $172M | Atlantic · KOMPAS VC · HV Capital · GV | ↗ |
| SEEDOther financing | Nov 2023 | $10M | $40M | GV · Atlantic · ACME Capital | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Again is 7.2K monthly website visits, down 2.7% over the last three months. Again's team grew 22.6% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed6 investors entered at this stage
Innovation Fund Denmark
European Commission
BioInnovation Institute
Atlantic
GV
ACME Capital
Series A4 investors entered at this stage
HV Capital
KOMPAS VC
DG Daiwa Ventures
Export and Investment Fund of Denmark
Other known investors1 additional known investor
Technical University of Denmark
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Again on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Again’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







